SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-22
👔
Aktis Oncology, Inc.
@AKTS_InsiderForm 4 Filing: Herrmann Ken Sells $122,133.023 of $AKTS
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
Aktis Oncology, Inc.
Ticker: $AKTS
Transaction Value
$122,133.023
Price/Share: $12.58
transaction date
2026-07-20
Shares: 9,712
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Herrmann Ken, holds the title of Director at Aktis Oncology, Inc..
On 2026-07-20, the insider transacted 9,712 shares.The shares were transacted at a weighted average price of $12.58 per share, resulting in a total market-relevant value of $122,133.023.
Executive Summary Summary
Herrmann Ken (Director) sold $122K of $AKTS
Post-Transaction Position: 1,350 shares
SEC Accession No: 0001193125-26-310991 (CIK: 2049757)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.